These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 28681133)
1. Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction. Shah SJ J Cardiovasc Transl Res; 2017 Jun; 10(3):322-336. PubMed ID: 28681133 [TBL] [Abstract][Full Text] [Related]
2. Precision Medicine for Heart Failure with Preserved Ejection Fraction: An Overview. Shah SJ J Cardiovasc Transl Res; 2017 Jun; 10(3):233-244. PubMed ID: 28585183 [TBL] [Abstract][Full Text] [Related]
3. Heart Failure with Preserved Ejection Fraction Trials Have Heterogeneous Control Groups: a Comparison of Kaplan-Meier Curves. Luo H; Zhang C; Wang J; Zhu J; Jia X Cardiovasc Drugs Ther; 2018 Dec; 32(6):577-580. PubMed ID: 30187346 [TBL] [Abstract][Full Text] [Related]
4. Advances in the pharmacotherapy of chronic heart failure with preserved ejection fraction: an ideal opportunity for precision medicine. Polsinelli VB; Shah SJ Expert Opin Pharmacother; 2017 Mar; 18(4):399-409. PubMed ID: 28129699 [TBL] [Abstract][Full Text] [Related]
5. [Heart failure with preserved ejection fraction: an update on diagnosis and treatment]. Gori M; D'Elia E; Zambelli G; Senni M G Ital Cardiol (Rome); 2020 Feb; 21(2):119-127. PubMed ID: 32051635 [TBL] [Abstract][Full Text] [Related]
6. Tensor Factorization for Precision Medicine in Heart Failure with Preserved Ejection Fraction. Luo Y; Ahmad FS; Shah SJ J Cardiovasc Transl Res; 2017 Jun; 10(3):305-312. PubMed ID: 28116551 [TBL] [Abstract][Full Text] [Related]
7. Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment. Xanthopoulos A; Triposkiadis F; Starling RC Trends Cardiovasc Med; 2018 Aug; 28(6):392-400. PubMed ID: 29471985 [TBL] [Abstract][Full Text] [Related]
8. Noncardiac comorbidities in heart failure with preserved ejection fraction - commonly ignored fact. Liu M; Fang F; Yu CM Circ J; 2015; 79(5):954-9. PubMed ID: 25739578 [TBL] [Abstract][Full Text] [Related]
9. Phenomapping Heart Failure with Preserved Ejection Fraction Using Machine Learning Cluster Analysis: Prognostic and Therapeutic Implications. Galli E; Bourg C; Kosmala W; Oger E; Donal E Heart Fail Clin; 2021 Jul; 17(3):499-518. PubMed ID: 34051979 [TBL] [Abstract][Full Text] [Related]
10. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials. Fukuta H; Goto T; Wakami K; Ohte N Eur J Prev Cardiol; 2016 Jan; 23(1):78-85. PubMed ID: 25520380 [TBL] [Abstract][Full Text] [Related]
11. How to Develop and Implement a Specialized Heart Failure with Preserved Ejection Fraction Clinical Program. Shah SJ; Cogswell R; Ryan JJ; Sharma K Curr Cardiol Rep; 2016 Dec; 18(12):122. PubMed ID: 27796858 [TBL] [Abstract][Full Text] [Related]
12. INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design. Reddy YNV; Lewis GD; Shah SJ; LeWinter M; Semigran M; Davila-Roman VG; Anstrom K; Hernandez A; Braunwald E; Redfield MM; Borlaug BA Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28476756 [TBL] [Abstract][Full Text] [Related]
13. 20th Annual Feigenbaum Lecture: Echocardiography for Precision Medicine-Digital Biopsy to Deconstruct Biology. Shah SJ J Am Soc Echocardiogr; 2019 Nov; 32(11):1379-1395.e2. PubMed ID: 31679580 [TBL] [Abstract][Full Text] [Related]
14. Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review. Vaduganathan M; Michel A; Hall K; Mulligan C; Nodari S; Shah SJ; Senni M; Triggiani M; Butler J; Gheorghiade M Eur J Heart Fail; 2016 Jan; 18(1):54-65. PubMed ID: 26634799 [TBL] [Abstract][Full Text] [Related]
15. The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies. Fukuta H; Goto T; Wakami K; Ohte N Int J Cardiol; 2017 Feb; 228():4-10. PubMed ID: 27863360 [TBL] [Abstract][Full Text] [Related]
16. Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project. Donal E; Lund L; Linde C; Daubert JC; Arch Cardiovasc Dis; 2010; 103(6-7):404-10. PubMed ID: 20800804 [TBL] [Abstract][Full Text] [Related]
17. Text Mining of the Electronic Health Record: An Information Extraction Approach for Automated Identification and Subphenotyping of HFpEF Patients for Clinical Trials. Jonnalagadda SR; Adupa AK; Garg RP; Corona-Cox J; Shah SJ J Cardiovasc Transl Res; 2017 Jun; 10(3):313-321. PubMed ID: 28585184 [TBL] [Abstract][Full Text] [Related]
18. Advances in Machine Learning Approaches to Heart Failure with Preserved Ejection Fraction. Ahmad FS; Luo Y; Wehbe RM; Thomas JD; Shah SJ Heart Fail Clin; 2022 Apr; 18(2):287-300. PubMed ID: 35341541 [TBL] [Abstract][Full Text] [Related]
19. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology. Janiaud P; Serghiou S; Ioannidis JPA Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165 [TBL] [Abstract][Full Text] [Related]